LATEST NEWS: 24 February 2026
The first Australian participant has been recruited to take part in an innovative trial that could mark a shift in how radiation therapy is delivered in lung cancer.
Led by Professor Paul Keall, Director of the Image X Institute at the University of Sydney (pictured above), the USyd/TROG 21.08 VITaL (Ventilation Imaging for Thoracic Lung cancer radiation therapy) trial is investigating a novel imaging modality that could reduce radiation therapy side effects, improving quality of life for patients with…